Organoids are simple tissue-engineered cell-based in vitro models that recapitulate many
aspects of the complex structure and function of the corresponding in vivo tissue. They can …

For decades, insight into fundamental principles of human biology and disease has been
obtained primarily by experiments in animal models. While this has allowed researchers to …

Organ‐and tissue‐level biological functions are intimately linked to microscale cell–cell
interactions and to the overarching tissue architecture. Together, biofabrication and …

It has been 15 years since the birth of human induced pluripotent stem cell (iPSC)
technology in 2007, and the scope of its application has been expanding. In addition to the …

The hepatitis E virus (HEV) was initially thought to exclusively cause acute hepatitis.
However, the first diagnosis of chronic hepatitis E in transplant recipients in 2008 profoundly …

Human pluripotent stem cells (hPSCs) and three-dimensional organoids have ushered in a
new era for disease modeling and drug discovery. Over the past decade, significant …

Metabolic diseases, including obesity, diabetes mellitus and cardiovascular disease, are a
major threat to health in the modern world, but efforts to understand the underlying …

Hepatotropic viruses naturally have narrow host and tissue tropisms, challenging the
development of robust experimental models. The advent of organoid technology provides a …

The liver has been studied extensively due to the broad number of diseases affecting its vital
functions. However, therapeutic advances have been hampered by the lack of knowledge …

Mesenchymal stromal cell (MSC)‐derived small extracellular vesicles (sEVs) show
therapeutic potential in multiple disease models, including kidney injury. Clinical translation …